Table 6 An assessment of the food consumption changes affected by the 90-day oral administration of 7%-GNANA, a test substance to the male and female rats (n=10)

Weeks	Groups (mg/kg/day)a)
	G1%			G2			G3			G4
	Male	Female		Male	Female		Male	Female		Male	Female
0	23.3±1.67	16.6±1.35		22.7±1.38	15.9±1.03		22.2±0.99	16.1±1.25		23.0±1.17	15.2±2.36
1	21.7±1.62	14.2±1.14		21.0±1.27	14.2±0.80		20.2±1.58	13.9±0.55		20.4±1.08	13.6±0.95
2	23.3±1.53	15.0±1.80		22.8±1.63	13.8±0.71		21.9±1.53	13.9±0.10		22.0±0.83	14.4±0.68
3	25.0±2.04	15.8±0.84		23.8±1.79	15.2±0.91		22.8±1.64	15.3±0.50		22.3±0.94	15.3±0.25
4	25.7±2.00	15.3±0.46		23.9±1.40	15.0±0.73		23.2±1.48	15.3±0.85		22.4±0.92	15.5±0.49
5	26.2±2.45	16.4±1.15		24.6±1.56	15.4±1.07		23.4±1.49	15.4±0.90		22.8±0.59	15.2±0.26
6	25.5±2.37	16.1±0.77		24.4±1.65	15.5±0.97		23.4±1.89	14.6±1.17		22.6±0.61	14.7±0.54
7	25.1±2.45	15.6±1.32		23.8±1.33	15.5±1.92		23.3±2.43	15.0±1.12		22.7±0.57	15.0±1.17
8	24.8±2.33	16.6±1.08		23.5±1.10	15.0±1.41		22.9±2.81	15.2±0.82		22.3±0.38	15.1±1.57
9	24.3±2.16	16.1±1.24		23.8±1.62	14.3±0.75		23.1±2.40	14.7±0.84		22.7±0.43	14.4±0.37
10	24.4±2.00	15.3±1.36		23.4±1.37	14.3±0.73		22.5±2.41	14.6±0.71		21.7±0.42	13.8±0.74
11	24.2±2.01	15.0±0.83		23.3±1.58	14.3±0.83		22.8±2.38	14.5±0.51		21.9±0.63	14.7±0.72
12	24.4±2.13	15.5±0.95		23.7±1.61	15.1±1.03		22.0±1.84	14.3±1.15		21.6±0.24	15.1±0.21
13	19.8±1.71	13.7±1.05		19.5±1.76	13.1±1.28		17.7±0.82	12.7±0.63		18.4±0.29	12.0±1.10
Average	24.1±1.96	15.5±0.57		23.2±1.39	14.8±0.50		22.2±1.72	14.7±0.45		21.9±0.39	14.6±0.48*

^* Significantly different from the controls at levels of p<0.05.
^* Significantly different from the controls at levels of p<0.05.%: Control group (G1), Low-dose group (G2: 1,250 mg/10 mL/day), Medium-dose group (G3: 2,500 mg/10 mL/day), High-dose group (G4: 5,000 mg/10 mL/day)
The data shown represent mean±S.D. (n=10).